These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16243166)

  • 1. Ulcerative cutaneous sarcoidosis responding to adalimumab.
    Philips MA; Lynch J; Azmi FH
    J Am Acad Dermatol; 2005 Nov; 53(5):917. PubMed ID: 16243166
    [No Abstract]   [Full Text] [Related]  

  • 2. Adalimumab for treatment of cutaneous sarcoidosis.
    Heffernan MP; Smith DI
    Arch Dermatol; 2006 Jan; 142(1):17-9. PubMed ID: 16415380
    [No Abstract]   [Full Text] [Related]  

  • 3. Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors.
    Wanat KA; Rosenbach M
    Arch Dermatol; 2012 Sep; 148(9):1097-100. PubMed ID: 22986883
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists.
    Thielen AM; Barde C; Saurat JH; Laffitte E
    Dermatology; 2009; 219(1):59-62. PubMed ID: 19468200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept.
    Field S; Regan AO; Sheahan K; Collins P
    Clin Exp Dermatol; 2010 Oct; 35(7):795-6. PubMed ID: 20831604
    [No Abstract]   [Full Text] [Related]  

  • 6. Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.
    Sweiss NJ; Curran J; Baughman RP
    Clin Dermatol; 2007; 25(3):341-6. PubMed ID: 17560312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adalimumab for treatment of severe ulcerative sarcoidosis.
    Vetos D; Wu DJ; Downing MB; Rajpara A
    Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized ulcerative sarcoidosis.
    Schwartz RA; Robertson DB; Tierney LM; McNutt NS
    Arch Dermatol; 1982 Nov; 118(11):931-3. PubMed ID: 7138054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of recalcitrant cutaneous sarcoidosis with adalimumab--a paradoxical effect? A case report.
    Santos G; Sousa LE; João AM
    An Bras Dermatol; 2013; 88(6 Suppl 1):26-8. PubMed ID: 24346872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis.
    Pariser RJ; Paul J; Hirano S; Torosky C; Smith M
    J Am Acad Dermatol; 2013 May; 68(5):765-73. PubMed ID: 23276549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases.
    Dhaille F; Viseux V; Caudron A; Dadban A; Tribout C; Boumier P; Clabaut A; Lok C
    Dermatology; 2010; 220(3):234-7. PubMed ID: 20185892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy.
    Mallbris L; Ljungberg A; Hedblad MA; Larsson P; Ståhle-Bäckdahl M
    J Am Acad Dermatol; 2003 Feb; 48(2):290-3. PubMed ID: 12582407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recalcitrant cutaneous sarcoidosis responding to infliximab.
    Heffernan MP; Anadkat MJ
    Arch Dermatol; 2005 Jul; 141(7):910-1. PubMed ID: 16027318
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
    Sweiss NJ; Welsch MJ; Curran JJ; Ellman MH
    Arthritis Rheum; 2005 Oct; 53(5):788-91. PubMed ID: 16208666
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Rosen T; Doherty C
    Dermatol Online J; 2007 Jul; 13(3):14. PubMed ID: 18328208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of rheumatoid vasculitis-associated skin ulcer with a TNF-α antagonist.
    Ashida A; Murata H; Mikoshiba Y; Ohashi A; Kobayashi A; Koga H; Uhara H; Okuyama R
    Int J Dermatol; 2014 Feb; 53(2):e154-6. PubMed ID: 23557520
    [No Abstract]   [Full Text] [Related]  

  • 17. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
    van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
    J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor (TNF) inhibitors.
    J Dermatolog Treat; 2004 Sep; 15(5):279. PubMed ID: 15370395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ulcerative form of skin sarcoidosis].
    Metz J; Hartmann A
    Z Hautkr; 1977 Sep; 52(17):890-6. PubMed ID: 910536
    [No Abstract]   [Full Text] [Related]  

  • 20. Etanercept ameliorates sarcoidosis arthritis and skin disease.
    Khanna D; Liebling MR; Louie JS
    J Rheumatol; 2003 Aug; 30(8):1864-7. PubMed ID: 12913948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.